United States· US:82160-726_2c494b27-5187-c3a8-e063-6394a90acd91
Derma Pella Sunscreen Advance Cream-Gel
A medicinal product containing ensulizole; titanium dioxide; octisalate; polysilicone-15; octocrylene; avobenzone, registered in United States by Pella Pharmaceuticals Co. Ltd.
Checked against FDA National Drug Code directory (United States) on
Informational only — not a medical device.
The record
At a glance
FDA National Drug Code directory (United States)- Active substance
- ENSULIZOLE; TITANIUM DIOXIDE; OCTISALATE; POLYSILICONE-15; OCTOCRYLENE; AVOBENZONE
- Manufacturer
- Pella Pharmaceuticals Co. Ltd
- Country
- United States (US)
- ATC code
- —
- Reimbursed
- Not published by this register
- Source register
- FDA National Drug Code directory (United States)
- Last checked
- July 26, 2026
Packs & prices · 2
- ndc1182160-726-01
- ndc1182160726011 TUBE in 1 CARTON (82160-726-01) / 50 g in 1 TUBE
Regulatory notes
No shortage, Orange Book or US label notes for this record.
Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of FDA National Drug Code directory (United States). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.
For developers
The same record over the API, and the raw payload
GET /v1/drugs/4c459747-d862-4ca6-887c-686d7863351a GET /v1/drugs/4c459747-d862-4ca6-887c-686d7863351a?format=fhir
Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.
{
"route": "TOPICAL",
"source": "ndc",
"strength": "50; 20; 50; 100; 20; 16",
"substance": "ENSULIZOLE; TITANIUM DIOXIDE; OCTISALATE; POLYSILICONE-15; OCTOCRYLENE; AVOBENZONE",
"productndc": "82160-726",
"dosage_form": "CREAM",
"dea_schedule": null,
"strength_unit": "mg/g; mg/g; mg/g; mg/g; mg/g; mg/g",
"application_number": "M020",
"marketing_category": "OTC MONOGRAPH DRUG"
}See everything about ensulizole; titanium dioxide; octisalate; polysilicone-15; octocrylene; avobenzone.
This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.